Eric Simpson, MD
Dermatology · Portland, ORNPI 1972511426
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Sanofi at 27.9% of the total. Among dermatology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 879 payments — averaging $1592.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$390K
- Pfizer$237K
- Sanofi-aventis U.S. LLC$139K
- Eli Lilly$134K
- LEO Pharma AS$118K
- AbbVie$61K
- plus $320K from 25 others
Across 1,842 payments — averaging $2074.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1.3M
- AbbVie$552K
- Pfizer$511K
- Eli Lilly$411K
- Incyte Corporation$231K
- Arcutis Biotherapeutics, Inc.$224K
- plus $557K from 12 others
What the payments were for
- Consulting fees$781,42756%
- Speaking & faculty fees$478,92634%
- Grants$1,0000%
- Travel & lodging$132,2949%
- Food & beverage$5,9500%
- Education$1050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 98 | $389,869 |
| Pfizer | 91 | $236,884 |
| Sanofi-aventis U.S. LLC | 51 | $139,465 |
| Eli Lilly | 83 | $134,190 |
| LEO Pharma AS | 139 | $118,167 |
| AbbVie | 104 | $61,446 |
| Incyte Corporation | 79 | $47,538 |
| LEO Pharma Inc. | 15 | $45,348 |
| Dermavant Sciences, Inc. | 19 | $40,493 |
| Amgen | 64 | $33,567 |
| Regeneron | 19 | $30,132 |
| Regeneron Healthcare Solutions, Inc. | 15 | $26,864 |
| Janssen Global Services, LLC | 24 | $12,878 |
| Dermira, Inc. | 23 | $12,693 |
| Lilly USA, LLC | 11 | $11,436 |
| GSK | 1 | $9,100 |
| Janssen Scientific Affairs, LLC | 1 | $7,508 |
| E.r. Squibb & Sons, L.L.C. | 3 | $7,425 |
| Galderma Laboratories, L.p. | 3 | $7,274 |
| Kyowa Kirin Pharmaceutical Development, Inc | 2 | $5,500 |
| Roche Products Limited | 3 | $5,168 |
| Boehringer Ingelheim International GmbH | 1 | $3,125 |
| UCB SA | 12 | $2,800 |
| Bausch Health US, LLC | 2 | $2,195 |
| Johnson & Johnson | 7 | $2,124 |
| Janssen Research & Development, LLC | 1 | $1,860 |
| Hoffmann-la Roche Limited | 4 | $1,741 |
| Novartis | 1 | $1,440 |
| Gilead | 1 | $700 |
| Merck | 1 | $610 |
| Organon | 1 | $164 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,399,702 in reported general payments places this provider in the 95th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 63 | $234,750 |
| Dupixent SyringeDupilumab | 34 | $130,667 |
| Tacrolimus | 37 | $4,518 |
| Clobetasol Propionate | 42 | $910 |
| Triamcinolone Acetonide | 49 | $651 |
| MethotrexateMethotrexate Sodium | 20 | $323 |
| Hydrocortisone | 13 | $148 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Portland
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
- Kathryn SchwarzenbergerPortland$34K
- Jon HanifinPortland$25K
- Phoebe RichPortland$17K
- Tracy FunkPortland$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.